文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma.

作者信息

Feng Bohai, Zhao Di, Zhang Zheng, Jia Ru, Schuler Patrick J, Hess Jochen

机构信息

Zhejiang Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China.

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany.

出版信息

NPJ Precis Oncol. 2025 Feb 28;9(1):57. doi: 10.1038/s41698-025-00844-6.


DOI:10.1038/s41698-025-00844-6
PMID:40021759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11871237/
Abstract

Head and neck squamous cell carcinoma (HNSC) is a prevalent malignancy, with HPV-negative tumors exhibiting aggressive behavior and poor prognosis. Understanding the intricate interactions within the tumor microenvironment (TME) is crucial for improving prognostic models and identifying therapeutic targets. Using BulkSignalR, we identified ligand-receptor interactions in HPV-negative TCGA-HNSC cohort (n = 395). A prognostic model incorporating 14 ligand-receptor pairs was developed using random forest survival analysis and LASSO-penalized Cox regression based on overall survival and progression-free interval of HPV-negative tumors from TCGA-HNSC. Multi-omics analysis revealed distinct molecular features between risk groups, including differences in extracellular matrix remodeling, angiogenesis, immune infiltration, and APOBEC enzyme activity. Deep learning-based tissue morphology analysis on HE-stained whole slide images further improved risk stratification, with region selection via Silicon enhancing accuracy. The integration of routine histopathology with deep learning and multi-omics data offers a clinically accessible tool for precise risk stratification, facilitating personalized treatment strategies in HPV-negative HNSC.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/6bd3415a5fe0/41698_2025_844_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/e1adc864db46/41698_2025_844_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/24bff79bb067/41698_2025_844_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/98428a51e249/41698_2025_844_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/794bb11e9f96/41698_2025_844_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/074ea45df80a/41698_2025_844_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/fe6fc0fa6f4f/41698_2025_844_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/f064c34e7f3f/41698_2025_844_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/6bd3415a5fe0/41698_2025_844_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/e1adc864db46/41698_2025_844_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/24bff79bb067/41698_2025_844_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/98428a51e249/41698_2025_844_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/794bb11e9f96/41698_2025_844_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/074ea45df80a/41698_2025_844_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/fe6fc0fa6f4f/41698_2025_844_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/f064c34e7f3f/41698_2025_844_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e30b/11871237/6bd3415a5fe0/41698_2025_844_Fig8_HTML.jpg

相似文献

[1]
Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma.

NPJ Precis Oncol. 2025-2-28

[2]
E2F expression profiling-based subtypes in head and neck squamous cell carcinoma: clinical relevance, prognostic implications, and personalized therapy.

World J Surg Oncol. 2025-4-24

[3]
Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients.

Front Immunol. 2023

[4]
Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer.

Int J Mol Sci. 2023-8-22

[5]
FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma.

Biomolecules. 2022-10-12

[6]
Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma.

J Cancer. 2023-6-12

[7]
Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma.

Front Genet. 2022-10-21

[8]
DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma.

Cell Oncol (Dordr). 2024-8

[9]
Comparisons of Forecasting for Survival Outcome for Head and Neck Squamous Cell Carcinoma by using Machine Learning Models based on Multi-omics.

Curr Genomics. 2022-6-10

[10]
Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.

J Gene Med. 2024-1

本文引用的文献

[1]
Basal-to-inflammatory transition and tumor resistance via crosstalk with a pro-inflammatory stromal niche.

Nat Commun. 2024-9-17

[2]
APOBEC family reshapes the immune microenvironment and therapy sensitivity in clear cell renal cell carcinoma.

Clin Exp Med. 2024-9-9

[3]
Cell-cell communication: new insights and clinical implications.

Signal Transduct Target Ther. 2024-8-7

[4]
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.

Nat Cancer. 2024-9

[5]
Advances in spatial transcriptomics and its applications in cancer research.

Mol Cancer. 2024-6-20

[6]
IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation.

Cancer Lett. 2024-5-1

[7]
m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/Nrf2 pathways.

Cancer Lett. 2024-4-10

[8]
miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression.

Pathol Res Pract. 2024-1

[9]
Neuropathologist-level integrated classification of adult-type diffuse gliomas using deep learning from whole-slide pathological images.

Nat Commun. 2023-10-11

[10]
Novobiocin blocks nucleic acid binding to Polθ and inhibits stimulation of its ATPase activity.

Nucleic Acids Res. 2023-10-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索